Approval · Notice of Compliance 17220 · 2015
EVICEL: Notice of Compliance 17220
Issued August 21, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17220
- Date
- August 21, 2015
- Company
- Omrix Biopharmaceuticals LtdNess Ziona, Israel
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: suture line sealing in dura mater closure
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVICEL | Not yet assigned | — |
Medicinal ingredients
- THROMBIN (HUMAN) 1,200 UNIT per ML
- FIBRINOGEN (HUMAN) 90 MG per ML